Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Cost and cost-effectiveness of soil-transmitted helminth treatment programmes : systematic review and research needs

Tools
- Tools
+ Tools

Turner, Hugo C., Truscott, James E., Hollingsworth, T. Déirdre, Bettis, Alison A., Brooker, Simon J. and Anderson, Roy M. (2015) Cost and cost-effectiveness of soil-transmitted helminth treatment programmes : systematic review and research needs. Parasites & Vectors, Volume 8 (Number 1). Article number 355. doi:10.1186/s13071-015-0885-3 ISSN 1756-3305.

[img]
Preview
PDF (Creative Commons : Attribution 4.0)
WRAP_s13071-015-0885-3_.pdf - Published Version - Requires a PDF viewer.

Download (3515Kb) | Preview
Official URL: http://dx.doi.org/10.1186/s13071-015-0885-3

Request Changes to record.

Abstract

Background In this time of rapidly expanding mass drug administration (MDA) coverage and the new commitments for soil-transmitted helminth (STH) control, it is essential that resources are allocated in an efficient manner to have the greatest impact. However, many questions remain regarding how best to deliver STH treatment programmes; these include which age-groups should be targeted and how often. To perform further analyses to investigate what the most cost-effective control strategies are in different settings, accurate cost data for targeting different age groups at different treatment frequencies (in a range of settings) are essential. Methods Using the electronic databases PubMed, MEDLINE, and ISI Web of Knowledge, we perform a systematic review of costing studies and cost-effectiveness evaluations for potential STH treatment strategies. We use this review to highlight research gaps and outline the key future research needs. Results We identified 29 studies reporting costs of STH treatment and 17 studies that investigated its cost-effectiveness. The majority of these pertained to programmes only targeting school-aged children (SAC), with relatively few studies investigating alternative preventive chemotherapy (PCT) treatment strategies. The methods of cost data collection, analysis and reporting were highly variable among the different studies. Only four of the costing studies were found to have high applicability for use in forthcoming economic evaluations. There are also very few studies quantifying the costs of increasing the treatment frequency. Conclusions The absence of cost data and inconsistencies in the collection and analysis methods constitutes a major research gap for STH control. Detailed and accurate costs of targeting different age groups or increasing treatment frequency will be essential to formulate cost-effective public health policy. Defining the most cost-effective control strategies in different settings is of high significance during this period of expanding MDA coverage and new resource commitments for STH control.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- )
Faculty of Science, Engineering and Medicine > Science > Mathematics
Library of Congress Subject Headings (LCSH): Helminthiasis -- Treatment
Journal or Publication Title: Parasites & Vectors
Publisher: BioMed Central Ltd.
ISSN: 1756-3305
Official Date: 3 July 2015
Dates:
DateEvent
3 July 2015Available
5 May 2015Accepted
1 May 2015Submitted
Volume: Volume 8
Number: Number 1
Article Number: Article number 355
DOI: 10.1186/s13071-015-0885-3
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 30 December 2015
Date of first compliant Open Access: 30 December 2015
Funder: GlaxoSmithKline, Bill & Melinda Gates Foundation, Wellcome Trust (London, England)
Grant number: OPP1033751 (BMGF), 098045 (WT)

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us